Last checked at 11 Oct 2019 16:17
Polarean Imaging Plc
("Polarean" or the "Company")
Director Dealing
Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 10 October 2019 that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 1,540,000 Ordinary Shares of £0.00037 ("Ordinary Shares") at a price of 13.06 pence per share on 8 October 2019.
Following this transaction, Dr Allis now holds a beneficial interest in 1,540,000 Ordinary Shares, representing approximately 1.35 per cent. of the Company's issued share capital.
Enquiries:
Polarean Imaging plc | www.polarean.com / www.polarean-ir.com | |||
Richard Hullihen, Chief Executive Officer | Via Walbrook PR | |||
Richard Morgan, Chairman |
| |||
|
| |||
SP Angel Corporate Finance LLP | Tel: +44 (0)20 3470 0470 | |||
David Hignell / Soltan Tagiev (Corporate Finance) |
| |||
Vadim Alexandre / Rob Rees (Corporate Broking) |
| |||
| ||||
Walbrook PR | Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com | |||
Anna Dunphy / Paul McManus | Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893 | |||
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:
1. | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name: | Dr Jonathan Allis | ||||||
2. | Reason for the notification | |||||||
a) | Position/status: | Non-Executive Director | ||||||
b) | Initial notification/Amendment: | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name: | Polarean Imaging Plc | ||||||
b) | LEI: | 213800DGR2BHXJ36OL37 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument: Identification code:
| Ordinary shares of £0.00037 GB00BF3DT583 | ||||||
b) | Nature of the transaction: | Purchase of shares | ||||||
c) | Price(s) and volume(s): |
| ||||||
d) | Aggregated information: Aggregated volume: Price: | Single transaction as in 4 c) above
| ||||||
e) | Date of the transaction: | 15.48hrs on 8 October 2019 | ||||||
f) | Place of the transaction: | Outside a trading venue | ||||||